img

Global HER2 Antibody Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global HER2 Antibody Market Insights, Forecast to 2034

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
Market Analysis and InsightsGlobal HER2 Antibody Market
Global HER2 Antibody market is expected to reach to US$ 15130 million in 2024, with a positive growth of %, compared with US$ 13980 million in 2022. Backed with the increasing demand from downstream industries, HER2 Antibody industry is evaluated to reach US$ 23040 million in 2029. The CAGR will be 7.3% during 2024 to 2029.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
Report Covers
This report presents an overview of global HER2 Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global HER2 Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus

Segment by Application


Hospital
Medical Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, HER2 Antibody introduction, etc. HER2 Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of HER2 Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab Emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Medical Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Antibody Market Perspective (2018-2029)
2.2 Global HER2 Antibody Growth Trends by Region
2.2.1 HER2 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 HER2 Antibody Historic Market Size by Region (2018-2024)
2.2.3 HER2 Antibody Forecasted Market Size by Region (2024-2029)
2.3 HER2 Antibody Market Dynamics
2.3.1 HER2 Antibody Industry Trends
2.3.2 HER2 Antibody Market Drivers
2.3.3 HER2 Antibody Market Challenges
2.3.4 HER2 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue HER2 Antibody by Players
3.1.1 Global HER2 Antibody Revenue by Players (2018-2024)
3.1.2 Global HER2 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of HER2 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global HER2 Antibody Market Concentration Ratio
3.4.1 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2022
3.5 Global Key Players of HER2 Antibody Head office and Area Served
3.6 Global Key Players of HER2 Antibody, Product and Application
3.7 Global Key Players of HER2 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibody Breakdown Data by Type
4.1 Global HER2 Antibody Historic Market Size by Type (2018-2024)
4.2 Global HER2 Antibody Forecasted Market Size by Type (2024-2029)
5 HER2 Antibody Breakdown Data by Application
5.1 Global HER2 Antibody Historic Market Size by Application (2018-2024)
5.2 Global HER2 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America HER2 Antibody Market Size (2018-2029)
6.2 North America HER2 Antibody Market Size by Type
6.2.1 North America HER2 Antibody Market Size by Type (2018-2024)
6.2.2 North America HER2 Antibody Market Size by Type (2024-2029)
6.2.3 North America HER2 Antibody Market Share by Type (2018-2029)
6.3 North America HER2 Antibody Market Size by Application
6.3.1 North America HER2 Antibody Market Size by Application (2018-2024)
6.3.2 North America HER2 Antibody Market Size by Application (2024-2029)
6.3.3 North America HER2 Antibody Market Share by Application (2018-2029)
6.4 North America HER2 Antibody Market Size by Country
6.4.1 North America HER2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America HER2 Antibody Market Size by Country (2018-2024)
6.4.3 North America HER2 Antibody Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe HER2 Antibody Market Size (2018-2029)
7.2 Europe HER2 Antibody Market Size by Type
7.2.1 Europe HER2 Antibody Market Size by Type (2018-2024)
7.2.2 Europe HER2 Antibody Market Size by Type (2024-2029)
7.2.3 Europe HER2 Antibody Market Share by Type (2018-2029)
7.3 Europe HER2 Antibody Market Size by Application
7.3.1 Europe HER2 Antibody Market Size by Application (2018-2024)
7.3.2 Europe HER2 Antibody Market Size by Application (2024-2029)
7.3.3 Europe HER2 Antibody Market Share by Application (2018-2029)
7.4 Europe HER2 Antibody Market Size by Country
7.4.1 Europe HER2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe HER2 Antibody Market Size by Country (2018-2024)
7.4.3 Europe HER2 Antibody Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China HER2 Antibody Market Size (2018-2029)
8.2 China HER2 Antibody Market Size by Type
8.2.1 China HER2 Antibody Market Size by Type (2018-2024)
8.2.2 China HER2 Antibody Market Size by Type (2024-2029)
8.2.3 China HER2 Antibody Market Share by Type (2018-2029)
8.3 China HER2 Antibody Market Size by Application
8.3.1 China HER2 Antibody Market Size by Application (2018-2024)
8.3.2 China HER2 Antibody Market Size by Application (2024-2029)
8.3.3 China HER2 Antibody Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia HER2 Antibody Market Size (2018-2029)
9.2 Asia HER2 Antibody Market Size by Type
9.2.1 Asia HER2 Antibody Market Size by Type (2018-2024)
9.2.2 Asia HER2 Antibody Market Size by Type (2024-2029)
9.2.3 Asia HER2 Antibody Market Share by Type (2018-2029)
9.3 Asia HER2 Antibody Market Size by Application
9.3.1 Asia HER2 Antibody Market Size by Application (2018-2024)
9.3.2 Asia HER2 Antibody Market Size by Application (2024-2029)
9.3.3 Asia HER2 Antibody Market Share by Application (2018-2029)
9.4 Asia HER2 Antibody Market Size by Region
9.4.1 Asia HER2 Antibody Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia HER2 Antibody Market Size by Region (2018-2024)
9.4.3 Asia HER2 Antibody Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America HER2 Antibody Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America HER2 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America HER2 Antibody Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America HER2 Antibody Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America HER2 Antibody Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America HER2 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America HER2 Antibody Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America HER2 Antibody Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America HER2 Antibody Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America HER2 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America HER2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America HER2 Antibody Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America HER2 Antibody Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Company Details
11.1.2 Genentech Inc Business Overview
11.1.3 Genentech Inc HER2 Antibody Introduction
11.1.4 Genentech Inc Revenue in HER2 Antibody Business (2018-2024)
11.1.5 Genentech Inc Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG HER2 Antibody Introduction
11.2.4 Novartis AG Revenue in HER2 Antibody Business (2018-2024)
11.2.5 Novartis AG Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer HER2 Antibody Introduction
11.3.4 Pfizer Revenue in HER2 Antibody Business (2018-2024)
11.3.5 Pfizer Recent Developments
11.4 Abnova Corporation
11.4.1 Abnova Corporation Company Details
11.4.2 Abnova Corporation Business Overview
11.4.3 Abnova Corporation HER2 Antibody Introduction
11.4.4 Abnova Corporation Revenue in HER2 Antibody Business (2018-2024)
11.4.5 Abnova Corporation Recent Developments
11.5 InvivoGen
11.5.1 InvivoGen Company Details
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibody Introduction
11.5.4 InvivoGen Revenue in HER2 Antibody Business (2018-2024)
11.5.5 InvivoGen Recent Developments
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibody Introduction
11.6.4 Celltrion Revenue in HER2 Antibody Business (2018-2024)
11.6.5 Celltrion Recent Developments
11.7 Biocon Limited
11.7.1 Biocon Limited Company Details
11.7.2 Biocon Limited Business Overview
11.7.3 Biocon Limited HER2 Antibody Introduction
11.7.4 Biocon Limited Revenue in HER2 Antibody Business (2018-2024)
11.7.5 Biocon Limited Recent Developments
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne HER2 Antibody Introduction
11.8.4 Bio-Techne Revenue in HER2 Antibody Business (2018-2024)
11.8.5 Bio-Techne Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HER2 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab Emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global HER2 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global HER2 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global HER2 Antibody Market Share by Region (2018-2024)
Table 11. Global HER2 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global HER2 Antibody Market Share by Region (2024-2029)
Table 13. HER2 Antibody Market Trends
Table 14. HER2 Antibody Market Drivers
Table 15. HER2 Antibody Market Challenges
Table 16. HER2 Antibody Market Restraints
Table 17. Global HER2 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global HER2 Antibody Revenue Share by Players (2018-2024)
Table 19. Global Top HER2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibody as of 2022)
Table 20. Global HER2 Antibody Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by HER2 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of HER2 Antibody, Headquarters and Area Served
Table 23. Global Key Players of HER2 Antibody, Product and Application
Table 24. Global Key Players of HER2 Antibody, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global HER2 Antibody Revenue Market Share by Type (2018-2024)
Table 28. Global HER2 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global HER2 Antibody Revenue Market Share by Type (2024-2029)
Table 30. Global HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global HER2 Antibody Revenue Share by Application (2018-2024)
Table 32. Global HER2 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global HER2 Antibody Revenue Share by Application (2024-2029)
Table 34. North America HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America HER2 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America HER2 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America HER2 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America HER2 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America HER2 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe HER2 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe HER2 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe HER2 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe HER2 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe HER2 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 48. China HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 49. China HER2 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 50. China HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 51. China HER2 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia HER2 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia HER2 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia HER2 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia HER2 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia HER2 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America HER2 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America HER2 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America HER2 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America HER2 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America HER2 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America HER2 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America HER2 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 66. Genentech Inc Company Details
Table 67. Genentech Inc Business Overview
Table 68. Genentech Inc HER2 Antibody Product
Table 69. Genentech Inc Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 70. Genentech Inc Recent Developments
Table 71. Novartis AG Company Details
Table 72. Novartis AG Business Overview
Table 73. Novartis AG HER2 Antibody Product
Table 74. Novartis AG Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 75. Novartis AG Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer HER2 Antibody Product
Table 79. Pfizer Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Abnova Corporation Company Details
Table 82. Abnova Corporation Business Overview
Table 83. Abnova Corporation HER2 Antibody Product
Table 84. Abnova Corporation Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 85. Abnova Corporation Recent Developments
Table 86. InvivoGen Company Details
Table 87. InvivoGen Business Overview
Table 88. InvivoGen HER2 Antibody Product
Table 89. InvivoGen Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 90. InvivoGen Recent Developments
Table 91. Celltrion Company Details
Table 92. Celltrion Business Overview
Table 93. Celltrion HER2 Antibody Product
Table 94. Celltrion Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 95. Celltrion Recent Developments
Table 96. Biocon Limited Company Details
Table 97. Biocon Limited Business Overview
Table 98. Biocon Limited HER2 Antibody Product
Table 99. Biocon Limited Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 100. Biocon Limited Recent Developments
Table 101. Bio-Techne Company Details
Table 102. Bio-Techne Business Overview
Table 103. Bio-Techne HER2 Antibody Product
Table 104. Bio-Techne Revenue in HER2 Antibody Business (2018-2024) & (US$ Million)
Table 105. Bio-Techne Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global HER2 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Trastuzumab Features
Figure 4. Lapatinib Features
Figure 5. Ado-trastuzumab Emtansine Features
Figure 6. Pertuzumab Features
Figure 7. Everolimus Features
Figure 8. Global HER2 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global HER2 Antibody Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Medical Center Case Studies
Figure 12. HER2 Antibody Report Years Considered
Figure 13. Global HER2 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global HER2 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global HER2 Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global HER2 Antibody Market Share by Players in 2022
Figure 17. Global Top HER2 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by HER2 Antibody Revenue in 2022
Figure 19. North America HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America HER2 Antibody Market Share by Type (2018-2029)
Figure 21. North America HER2 Antibody Market Share by Application (2018-2029)
Figure 22. North America HER2 Antibody Market Share by Country (2018-2029)
Figure 23. United States HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe HER2 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe HER2 Antibody Market Share by Type (2018-2029)
Figure 27. Europe HER2 Antibody Market Share by Application (2018-2029)
Figure 28. Europe HER2 Antibody Market Share by Country (2018-2029)
Figure 29. Germany HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China HER2 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China HER2 Antibody Market Share by Type (2018-2029)
Figure 37. China HER2 Antibody Market Share by Application (2018-2029)
Figure 38. Asia HER2 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia HER2 Antibody Market Share by Type (2018-2029)
Figure 40. Asia HER2 Antibody Market Share by Application (2018-2029)
Figure 41. Asia HER2 Antibody Market Share by Region (2018-2029)
Figure 42. Japan HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America HER2 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America HER2 Antibody Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America HER2 Antibody Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America HER2 Antibody Market Share by Country (2018-2029)
Figure 52. Brazil HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries HER2 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Genentech Inc Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 59. Novartis AG Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 60. Pfizer Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 61. Abnova Corporation Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 62. InvivoGen Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 63. Celltrion Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 64. Biocon Limited Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 65. Bio-Techne Revenue Growth Rate in HER2 Antibody Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries